Pacira Pharma (PCRX) Reports In-Line Q1 EPS

Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $74.6 million versus the consensus estimate of $73.69 million.

• Pacira reiterated its full year 2018 financial guidance

For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.

You May Also Be Interested In

• Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
• West Bancorporation (WTBA) Tops Q1 EPS by 8c
• Cullen/Frost Bankers (CFR) Misses Q1 EPS by 3c